235 related articles for article (PubMed ID: 31882737)
1. Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients.
Paradowska E; Jabłońska A; Studzińska M; Wilczyński M; Wilczyński JR
Sci Rep; 2019 Dec; 9(1):19935. PubMed ID: 31882737
[TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
3. Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.
O'Shannessy DJ; Somers EB; Wang LC; Wang H; Hsu R
J Ovarian Res; 2015 May; 8():29. PubMed ID: 25971554
[TBL] [Abstract][Full Text] [Related]
4. The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer.
Bilyk OO; Pande NT; Pejovic T; Buchinska LG
Exp Oncol; 2014 Jun; 36(2):121-4. PubMed ID: 24980768
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level.
Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E
Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.
O'Shannessy DJ; Jackson SM; Twine NC; Hoffman BE; Dezso Z; Agoulnik SI; Somers EB
Int J Mol Sci; 2013 Jul; 14(7):13687-703. PubMed ID: 23880844
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
8. Viral and bacterial aetiologies of epithelial ovarian cancer.
Shanmughapriya S; Senthilkumar G; Vinodhini K; Das BC; Vasanthi N; Natarajaseenivasan K
Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2311-7. PubMed ID: 22402815
[TBL] [Abstract][Full Text] [Related]
9. The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.
Zhu Q; Tang M; Wang X
Cancer Biol Ther; 2017 Apr; 18(4):222-228. PubMed ID: 28278071
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus in squamous cell carcinoma arising from dermoid cysts.
Chiang AJ; Chen DR; Cheng JT; Chang TH
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):559-66. PubMed ID: 26522111
[TBL] [Abstract][Full Text] [Related]
11. Possible Epithelial Ovarian Cancer Association with HPV18 or HPV33 Infection.
Zhang PP; Zhou L; Cao JS; Li YP; Zeng Z; Sun N; Shen L; Zhu HY; Ruan Y; Zha WT; Wang XY; Zhang KQ; Zhang R
Asian Pac J Cancer Prev; 2016; 17(6):2959-64. PubMed ID: 27356718
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 expression by healthy and malignant ovarian epithelial cells.
Machelon V; Gaudin F; Camilleri-Broët S; Nasreddine S; Bouchet-Delbos L; Pujade-Lauraine E; Alexandre J; Gladieff L; Arenzana-Seisdedos F; Emilie D; Prévot S; Broët P; Balabanian K
BMC Cancer; 2011 Mar; 11():97. PubMed ID: 21410972
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
15. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
17. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
19. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N; Abubaker K; Findlay J; Quinn M
J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
Wang D; Zhu H; Ye Q; Wang C; Xu Y
Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]